Drug for treating hemophilia

Abstract

The invention discloses a drug for treating hemophilia. The drug is prepared from 15-25 parts by weight of buffalo horn, 15-25 parts by weight of unprocessed rehmannia root, 5-15 parts by weight of lalang grass rhizome, 5-15 parts by weight of stir-baked Gardenia jasminoides, 15-25 parts by weight of root bark of the peony tree, 10-20 parts by weight of red peony root, 10-20 parts by weight of radix scrophulariae, 10-15 parts by weight of nodus nelumbinis rhizomatis charcoal, 10-20 parts by weight of madder, 20-30 parts by weight of rheum officinale charcoal, 10-20 parts by weight of achyranthes root, 15-20 parts by weight of pseudo-ginseng, 5-10 parts by weight of Circium japonicum, 5-10 parts by weight of common cephalanoplos herb, 10-15 parts by weight of radix astragali, 10-20 parts by weight of donkey-hide gelatin, 15-20 parts by weight of pilose asiabell root, 15-25 parts by weight of licorice root, 10-20 parts by weight of pseudostellaria root, 20-30 parts by weight of Codonopsis pilosula Nannf., 10-20 parts by weight of radix angelicae sinensis, 20-25 parts by weight of radix aconiti lateralis praeparata slice, 10-20 parts by weight of fleece-flower root, 10-20 parts by weight of dark plum, 10-20 parts by weight of spatholobus stem, 15-20 parts by weight of ligusticum wallichii, 10-20 parts by weight of radix arnebiae seu lithospermi, 10-15 parts by weight of Radix et Rhizoma Rhei, 10-20 parts by weight of tortoiseshell and 5-10 parts by weight of carapax trionycis. Through dialectical compatibility, the drug has effects of dredging stasis and nourishing blood, nourishing yin and clearing heat, cooling blood and stopping bleeding, tonifying Qi and diminishing inflammation, has substantial hemophilia curative effects and has no toxic or side effects.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a medicine for treating hemophilia. Background technique [0002] Hemophilia is a group of inherited bleeding disorders, which is a severe coagulation disorder caused by the lack of certain coagulation factors in the blood. Typical patients often develop coagulation dysfunction since childhood, spontaneously or after mild trauma; thus, they often bleed continuously during trauma and surgery, and in severe cases, they can also spontaneously bleed after more strenuous activities. [0003] Hemophilia is a congenital hereditary disease. At present, there is no radical cure in both Chinese and Western medicine. The main method is the replacement therapy of coagulation factor infusion, but this method can only last for a short period of time. Patients need frequent transfusion of coagulation factors to maintain, but coagulation factors are expensive and cannot be...

AI Technical Summary

Problems solved by technology

[0003] Hemophilia is a congenital hereditary disease. At present, there is no radical cure in both Chinese and Western medicine. The main method is the replacement therapy of coagulation factor infusion, but this method can only last for a short period of time. It will decrease, and patients need frequent transfusion of coagulation factors to maintain, but coagulation factors are expensive and cannot be cured, and the economic burden is heavy